Finance

Stocks making the biggest moves premarket: Synopsys, Moderna, Micron Technology, Wynn

EA Builder

Check out the companies making headlines before the bell. Synopsys — The developer of design automation models and software jumped 8% after Nvidia invested $2 billion in Synopsys common stock at $414.79 per share as part of a broad strategic partnership. Leggett & Platt — Shares rose 14% after the furniture component manufacturer received an unsolicited, all-stock buyout proposal from Somnigroup International valued at $12 per share. Wynn Resorts — The hotel and casino chain added almost 2% after Goldman Sachs included Wynn on its conviction buy list. Goldman said the company has a “best-in-class” Las Vegas business, while improvement in China’s Macao region can “drive transformative upside.” Nvidia , Micron Technology , Marvell Technology — Some artificial intelligence-linked stocks traded down as investor concerns about an AI bubble grew. Nvidia slipped 1.4%, while Micron Technology and Marvell Technology each fell about 2%. Moderna — The MRNA vaccine maker fell 4% after the FDA’s Center for Biologics Evaluation and Research Director Vinay Prasad issued an internal memo that linked Moderna’s Covid-19 vaccines to the death of 10 children, per the New York Times. Coinbase , Mara Holdings — Cryptocurrency-linked stocks fell as traders continued to rotate out of risk-on investments. Mara Holdings shed 6.5%, while Coinbase traded nearly 4% lower. Cleanspark — The bitcoin mining stock fell more than 7%, reversing some of last week’s 55% gain. Cleanspark rallied last week as bitcoin traded back above $90,000. The digital currency shed more than 5% early Monday, however, pressuring Cleanspark. — CNBC’s Fred Imbert and Alex Harring contributed reporting

This article was originally published by a Cnbc.com. Read the Original article here. .

Share with your friends!

Leave a Reply

Your email address will not be published. Required fields are marked *

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.